NASDAQ:HEPA

Hepion Pharmaceuticals Stock Forecast

etoro logo Buy HEPA
*Your capital is at risk
$0.0535
+0 (+0%)
At Close: Jul 22, 2026
AI Analysis AI Analysis of HEPA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add HEPA to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Weaker technical forecast for Hepion Pharmaceuticals, Inc. as stock downgraded to Sell Candidate
(Updated on Jul 22, 2026)

Sell candidate since Jul 22, 2026

No changes to the price of Hepion Pharmaceuticals, Inc. stock on the last trading day (Wednesday, 22nd Jul 2026). During the last trading day the stock fluctuated 0% from a day low at $0.0535 to a day high of $0.0535. The price has risen in 4 of the last 10 days but is still down by -17.89% for this period.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.36% during the next 3 months and, with a 90% probability hold a price between $0.0335 and $0.0815 at the end of this 3-month period.

HEPA Signals & Forecast

There are few to no technical positive signals at the moment. The Hepion Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0548 and $0.0595. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 21, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Hepion Pharmaceuticals, Inc. stock

Hepion Pharmaceuticals, Inc. finds support from accumulated volume at $0.0515 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 12.68%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HEPA) For The Upcoming Trading Day Of Thursday 23rd

For the upcoming trading day on Thursday, 23rd we expect Hepion Pharmaceuticals, Inc. to open at $0.0535, and during the day (based on 14 day Average True Range), to move between $0.0482 and $0.0587, which gives a possible trading interval of +/-$0.0105 (+/-21.77%) up or down from last closing price. If Hepion Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 21.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0515 (3.69%) than the resistance at $0.0570 (6.59%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Hepion Pharmaceuticals, Inc. stock A Buy?

Hepion Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -3.256 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 23, 2026 - $0.0535 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

HEPA Performance

Trading levels for HEPA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0535 -
R2 0.0535 -
R1 0.0535 -
Price 0.0535
S1 0.0535 -
S2 0.0535 -
S3 0.0535 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0605 13.14%
R2 0.0600 12.20%
R1 0.0570 6.59%
Price 0.0535
S1 0.0515 -3.69%
S2 0.0505 -5.56%
S3 0.0410 -23.33%

FAQ

What is the symbol for Hepion Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Hepion Pharmaceuticals, Inc. is HEPA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Hepion Pharmaceuticals, Inc. Stock?
Hepion Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Hepion Pharmaceuticals, Inc. Stock?
Hepion Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Hepion Pharmaceuticals, Inc. Stock.

What's the current price of Hepion Pharmaceuticals, Inc. Stock?
As of the end of day on the Jul 22, 2026, the price of an Hepion Pharmaceuticals, Inc. (HEPA) share was $0.0535.

What is the 52-week high and low for Hepion Pharmaceuticals, Inc. Stock?
The 52-week high for Hepion Pharmaceuticals, Inc. Stock is $0.110 and the 52-week low is $0.0330.

What is the market capitalization of Hepion Pharmaceuticals, Inc. Stock?
As of the Jul 22, 2026, the market capitalization of Hepion Pharmaceuticals, Inc. is 617.116K.

When is the next earnings date for Hepion Pharmaceuticals, Inc.?
The upcoming earnings date for Hepion Pharmaceuticals, Inc. is Sep 02, 2026.
Click to get the best stock tips daily for free!
ABOUT HEPION PHARMACEUTICALS, INC.
Hepion Pharmaceuticals
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
6.70% Jul 13
JLL
$299.78
8.23% Jun 24
ROP
$331.60
5.76% Jun 24
NMRK
$15.02
4.79% Jun 24
CAG
$13.43
10.69% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE